9 days ago
Hyderābād, IndiaSenior
Responsibilities
- Work with data scientists to translate user needs and technical requirements into documented components.
- Implement API, retrieval, ML, pipeline, and approved AI-integration components with guidance.
- Prepare permitted datasets and record data sources, model versions, prompt versions, and reproducible results.
- Develop, test, and debug components using Python, SQL, and version control.
- Run regression, failure-case, acceptance, and specified AI tests; investigate issues and document results.
- Follow data-access, privacy, secret-management, and unsafe-AI-behavior controls.
- Support delivered products through improvements, technical documentation, handoffs, and training materials.
- Collaborate with Data Science, Clinical Development, IS, and data-platform partners across regions.
Requirements
- Master’s degree, or bachelor’s degree plus 2 years of related experience.
- 5 to 9 years of Data Engineer experience preferred.
- Preferred technical education includes computer science, data science, informatics, software engineering, statistics, or another technical discipline.
- Strong programming skills in Python and/or R and familiarity with SQL.
- Familiarity with version control, software testing, documentation, data structures, pipelines, APIs, and cloud environments.
- Basic machine learning and generative AI literacy, including the ability to run specified AI tests and record model, prompt, and data versions.
- Knowledge of software design, testing, debugging, maintainable code, secure data handling, privacy, access risks, and unsafe AI behavior.
- Ability to explain software behavior, data flows, and technical issues clearly and collaborate effectively.
- Internship or early-career pharmaceutical or high-tech industry experience is preferred.
About Amgen
Amgen is a public biotechnology company that discovers, develops, manufactures, and sells biologic and biosimilar therapeutics for patients with serious diseases. Its portfolio and pipeline span oncology, cardiovascular disease, osteoporosis, inflammation, and rare diseases, marketed globally through direct sales and partnerships. Founded in 1980 and headquartered in Thousand Oaks, California (NASDAQ: AMGN), Amgen is a component of the Dow Jones Industrial Average and completed the acquisition of Horizon Therapeutics in 2023.